Doctors Face Challenges In Treating Drug-Resistant TB Among Children

NPR’s “Shots” blog and “All Things Considered” on Tuesday reported on the challenges of treating children with tuberculosis (TB), particularly drug-resistant TB, a “growing epidemic.” TB drugs are not designed for children, which “means they aren’t packaged in smaller doses, and may not even have been tested for child-specific effectiveness or side effects,” the blog notes, quoting Christoph Hoehn, the acting country director for Médecins Sans Frontières in Tajikistan, who with colleagues has “been running a pilot project in Tajikistan since 2011 to treat children with drug-resistant TB.” The blog profiles the doctors’ efforts and the stories of several young TB patients (Beaubien, 7/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.